Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease

Movement Disorders

Volumn 25, Issue 9, 2010, Pages 1246-1252

  Josephs, Keith A ^a   Whitwell, Jennifer L ^a   Boeve, Bradley F ^a   Knopman, David S ^a   Petersen, Ronald C ^a   Hu, William T ^b   Parisi, Joseph E ^a   Dickson, Dennis W ^c   Jack Jr , Clifford R ^a  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Corticobasal degeneration; Corticobasal syndrome; Region of interest; Voxel based morphometry

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; CORTICOBASAL SYNDROME; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL LOBE; GRAY MATTER; GROUPS BY AGE; HEMISPHERIC DOMINANCE; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; SYNDROME; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY; BRAIN CORTEX; BRAIN MAPPING; EXTRAPYRAMIDAL SYNDROME; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING;

AGED; ALZHEIMER DISEASE; BASAL GANGLIA; BASAL GANGLIA DISEASES; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES;

EID: 77955060966     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23062     Document Type: Article

References (31)

1. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54 (Suppl 5):S15-S19.
2. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003;18:467-486.
3. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41-48.
4. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009;24:1375-1379.
5. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov Disord 2009;24:1593-1599.
6. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
7. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
8. Josephs KA, Duffy JR, Strand EA, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006;129:1385-1398.
9. Braak H and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropath (Berl) 1991;82:239-259.
10. Working Group. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's Disease. Neurobiol Aging 1997;18:S1-S2.
11. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
12. Senjem ML, Gunter JL, Shiung MM, Petersen RC, Jack CR, Jr. Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage 2005;26:600-608.
13. Whitwell JL, Przybelski S, Weigand SD, et al. 3D Maps from Multiple MRI illustrate changing atrophy patterns as subjects progress from MCI to AD. Brain 2007;130:1777-1786.
14. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289.
15. Whitwell JL, Przybelski SA, Weigand SD, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain 2009;132:2932-2946.
16. Josephs KA, Tang-Wai DF, Edland SD, et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004;61:1881-1884.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572. (Pubitemid 12124384)
19. Fahn S, Elton RL, Committee UD. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, Vol.2. Florham Park, NJ: MacMillian Healthcare Information; 1987. p 153-163, 293-304.
20. Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000;12:233-239.
21. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
22. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006;63:81-86. (Pubitemid 43063865)
23. Savoiardo M, Girotti F, Strada L, Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm Suppl 1994;42:93-110. (Pubitemid 24212881)
24. Soliveri P, Monza D, Paridi D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999;53:502-507.
25. Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008;29:280-289.
26. Whitwell JL, Jack CR, Jr., Kantarci K, et al. Imaging correlates of posterior cortical atrophy. Neurobiol Aging 2007;28:1051-1061. (Pubitemid 46635917)
27. Murray R, Neumann M, Forman MS, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 2007;68:1274-1283.
28. Whitwell JL, Jack CR, Jr., Parisi JE, et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 2007;130:1148-1158.
29. Whitwell JL, Weigand SD, Shiung MM, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain. 2007;130:708-719.
30. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872.
31. Horoupian DS, Wasserstein PH. Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol 1999;98:317-322.